ArticleScientific reports2025
Exploring the antimicrobial potential from various parts of Ziziphus mauritiana Lam.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phytochemical Characterization and Antioxidant, Antimicrobial, and Poultry Meat Preservation Potential ofFoods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Ziziphus mauritiana Lam., a tropical tree from the Rhamnaceae family, is valued for its nutritional benefits and traditional medicinal uses. This study assessed the antimicrobial activity of different plant parts which are leaves, roots, bark, stems, and fruits, against Escherichia coli and Fusarium solani using methanolic extracts at 1.0 mg/mL. Streptomycin (1.0 mg/mL) and 0.8% methanol served as positive and negative controls, respectively. Plant-derived antimicrobial agents are gaining attention for their bioavailability, safety, and low resistance potential. The methanolic extracts exhibited potent antimicrobial effects, with minimum bactericidal and fungicidal concentrations (MBC/MFC) of 0.8 mg/mL for E. coli and 1.0 mg/mL for F. solani. Leaf extracts showed the strongest inhibition, with zones of 101.47 mm² for E. coli and 88.11 mm² for F. solani, followed by root extracts (86.48 mm² against F. solani). The study supports Z. mauritiana's potential in treating human diseases and underscores the need for sustainable conservation. The results also emphasize the need to conserve this underutilized species for future pharmacological applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.